These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15587910)

  • 1. [Assessment of soluble intracellular adhesion molecule-1 (sICAM-1) in women with benign ovarian tumors].
    Rzymski P; Opala T; Woźniak J; Drews K; Sajdak S
    Ginekol Pol; 2004 Oct; 75(10):785-92. PubMed ID: 15587910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of serum sICAM-1 amd CA-125 in patients with ovarian tumors--preliminary report].
    Rzymski P; Woźniak J; Opala T; Sajdak S; Drews K
    Ginekol Pol; 2002 Nov; 73(11):1090-5. PubMed ID: 12722404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of soluble intracellular adhesion molecule-1 (sICAM-1) in benign and malignant ovarian masses.
    Opala T; Drews K; Rzymski P; Woźniak J; Sajdak S
    Eur J Gynaecol Oncol; 2003; 24(3-4):255-7. PubMed ID: 12807235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers.
    Callet N; Delaunay J; Pichon MF
    Eur J Gynaecol Oncol; 2000; 21(2):135-40. PubMed ID: 10843471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions.
    Altomonte M; Fonsatti E; Lamaj E; Cattarossi I; Cattelan A; Maio M
    Breast Cancer Res Treat; 1999 Nov; 58(1):19-23. PubMed ID: 10634514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary.
    Daraï E; Bringuier AF; Walker-Combrouze F; Feldmann G; Madelenat P; Scoazec JY
    Hum Reprod; 1998 Oct; 13(1O):2831-5. PubMed ID: 9804241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
    Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
    Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of Ca-125 in the differential diagnosis of adnexal mass in breast cancer patients].
    Grabiec M; Nowicki P; Walentowicz M; Greźlikowska U; Mierzwa T; Chmielewska W
    Ginekol Pol; 2005 May; 76(5):371-6. PubMed ID: 16145856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases.
    Sprenger A; Schardt C; Rotsch M; Zehrer M; Wolf M; Havemann K; Heymanns J
    J Cancer Res Clin Oncol; 1997; 123(11-12):632-8. PubMed ID: 9620222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The assessment of the dependence between antigen CA 125 and nicotinism in patients with benign ovarian tumors including endometrial cysts].
    Posadzka E; Jach R; Babczyk D; Knafel A; Pityński K
    Przegl Lek; 2014; 71(6):319-22. PubMed ID: 25344972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of serum concentrations of intercellular adhesion molecule-1 in patients with colorectal cancer.
    Kang X; Wang F; Xie JD; Cao J; Xian PZ
    World J Gastroenterol; 2005 Jul; 11(27):4250-3. PubMed ID: 16015700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
    Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.